AVDL
Avadel Pharmaceuticals PLC
NASDAQ: AVDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.64
+0.00% today
Updated 2026-02-12
Market cap
$2.12B
P/E ratio
0.00
P/S ratio
8.55x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$6 – $24
Volume
2.2M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
4.3
Growth
C5.5
Quality
C+2.5
Profitability
F8.3
Valuation
A3/9
Piotroski F-Score
Weak
-5.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$20.71
-4.30%
12-Month target
—
—
Intrinsic (DCF)
$73.50
Margin of safety
+70.56%
0 Strong Buy0 Buy10 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $23.25M — positive
+ 70.56% below intrinsic value
+ Debt/equity 0.38x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -5.40 — distress zone
- Thin margins at -0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $1.50M | $27.96M | $169.12M | $248.52M |
| Net income | $-77.33M | $-137.46M | $-160.28M | $-48.83M | $20000.00 |
| EPS | — | — | — | — | $0.00 |
| Free cash flow | $-77.34M | $-71.02M | $-128.51M | $-46.91M | $23.25M |
| Profit margin | — | -9,188.77% | -573.17% | -28.87% | -0.00% |
Peer comparison
Smart narrative
Avadel Pharmaceuticals PLC trades at $21.64. Our Smart Value Score of 41/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -5.40, it sits in the distress. TTM revenue stands at $248.52M. with profit margins at -0.00%. Our DCF model estimates intrinsic value at $73.50.
Frequently asked questions
What is Avadel Pharmaceuticals PLC's stock price?
Avadel Pharmaceuticals PLC (AVDL) trades at $21.64.
Is Avadel Pharmaceuticals PLC overvalued?
Smart Value Score 41/100 (Grade D, Sell). DCF value $73.50.
What is the price target of Avadel Pharmaceuticals PLC (AVDL)?
The analyst target price is $20.71, representing -4.3% downside from the current price of $21.64.
What is the intrinsic value of Avadel Pharmaceuticals PLC (AVDL)?
Based on our DCF model, intrinsic value is $73.50, a +70.6% margin of safety versus $21.64.
What is Avadel Pharmaceuticals PLC's revenue?
TTM revenue is $248.52M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-5.40 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio8.55x
ROE-0.00%
Beta1.63
50D MA$21.52
200D MA$15.84
Shares out0.10B
Float0.09B
Short ratio—
Avg volume2.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—